NCT01728402 2026-02-17Pathogenesis of Hematologic MalignanciesOHSU Knight Cancer InstituteEnrolling by invitation5,000 enrolled
NCT07383298 2026-02-03Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated PhasePeking University People's HospitalEnrolling by invitation100 enrolled
NCT00923442 2026-01-05Biology Studies of Hematologic CancersNational Institutes of Health Clinical Center (CC)Enrolling by invitation550 enrolled